Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models

International Immunopharmacology

Volumn 63, Issue , 2018, Pages 26-34

  Huang, Zihao ^a,c   Liu, Huiying ^b   Zhang, Xia ^a,c   Wen, Guoxia ^a,c   Zhu, Chen ^c   Zhao, Yanbin ^c   Niu, Wenkai ^b   Qin, Yanhong ^b   Chen, Huipeng ^c   Bai, Changqing ^b   Liu, Gang ^c  

^a ANHUI UNIVERSITY   (China)

^b Beijing 307 Hospital   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Acute lung injury; FTY720; hUC MSCs; Lipopolysaccharide; Transcriptomic analysis

Indexed keywords

FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; LIPOPOLYSACCHARIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE ONTOLOGY; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG PARENCHYMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTOMICS; TREATMENT OUTCOME; ACUTE LUNG INJURY; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; GENE EXPRESSION PROFILING; GENETICS; LUNG; METABOLISM; MULTIMODALITY CANCER THERAPY;

ACUTE LUNG INJURY; ANIMALS; COMBINED MODALITY THERAPY; FEMALE; FINGOLIMOD HYDROCHLORIDE; GENE EXPRESSION PROFILING; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE, INBRED C57BL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85050519405     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2018.06.036     Document Type: Article

References (41)

1. Matthay, M.A., Zemans, R.L., The acute respiratory distress syndrome: pathogenesis and treatment. Annu. Rev. Pathol. 6:1 (2011), 147–163.
2. Maybauer, M.O., Maybauer, D.M., Herndon, D.N., Incidence and outcomes of acute lung injury. N. Engl. J. Med. 131:2 (2006), 554–562.
3. Bernard, G.R., Artigas, A., Brigham, K.L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J.R., Morris, A., Spragg, R., Report of the American-European consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. J. Crit. Care 9:1 (1994), 72–81.
4. Network, A.R.D.S., Wheeler, A., Bernard, G., Thompson, B., Hayden, D., Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354:24 (2006), 2564–2575.
5. Network, A.R.D.S., Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 342:18 (2000), 1301–1308.
6. Rubenfeld, G.D., Caldwell, E., Peabody, E., Weaver, J., Martin, D.P., Neff, M., Stern, E.J., Hudson, L.D., Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353:16 (2005), 1685–1693.
7. Han, S., Mallampalli, R.K., The acute respiratory distress syndrome: from mechanism to translation. J. Immunol. 194:3 (2015), 855–860.
8. Li, Y.-m., Wei, H.-c., Present strategies and future perspectives for therapies of ALI/ARDS [J]. Chin. J. Pathophysiol., 4, 2009, 050.
9. Natarajan, V., Dudek, S.M., Jacobson, J.R., Morenovinasco, L., Huang, L.S., Abassi, T., Mathew, B., Zhao, Y., Wang, L., Bittman, R., Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am. J. Respir. Cell Mol. Biol. 49:1 (2013), 6–17.
10. Wilson, J.G., Liu, K.D., Zhuo, H., Caballero, L., McMillan, M., Fang, X., Cosgrove, K., Vojnik, R., Calfee, C.S., Lee, J.-W., Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 3:1 (2015), 24–32.
11. Volarevic, V., Gazdic, M., Simovic, M.B., Jovicic, N., Djonov, V., Arsenijevic, N., Mesenchymal stem cell-derived factors: immuno-modulatory effects and therapeutic potential. Biofactors, 43(5), 2017, 633.
12. Khubutiya, M.S., Vagabov, A.V., Temnov, A.A., Sklifas, A.N., Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy 16:5 (2014), 579–585.
13. Vosdoganes, P., Lim, R., Moss, T.J., Wallace, E.M., Cell therapy: a novel treatment approach for bronchopulmonary dysplasia. Pediatrics 130:4 (2012), 727–737.
14. Maron-Gutierrez, T., Silva, J.D., Asensi, K.D., Bakker-Abreu, I., Shan, Y., Diaz, B.L., Goldenberg, R.C., Mei, S.H., Stewart, D.J., Morales, M.M., Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Crit. Care Med. 41:11 (2013), 319–333.
15. Gupta, N., Su, X., Popov, B., Lee, J.W., Serikov, V., Matthay, M.A., Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol., 179(3), 2007, 1855.
16. Mei, S.H., Mccarter, S.D., Deng, Y., Parker, C.H., Liles, W.C., Stewart, D.J., Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med., 4(9), 2007, e269.
17. Merrill, A.H., Schmelz, E.M., Dillehay, D.L., Spiegel, S., Shayman, J.A., Schroeder, J.J., Riley, R.T., Voss, K.A., Wang, E., Sphingolipids—the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Appl. Pharmacol. 142:1 (1997), 208–225.
18. Liu, X., Zhang, Q.H., Yi, G.H., Regulation of metabolism and transport of sphingosine-1-phosphate in mammalian cells. Mol. Cell. Biochem., 363(1–2), 2012, 21.
19. Sugiura, T., Dohi, Y., Yamashita, S., Ohte, N., Ito, S., Iwaki, S., Hirowatari, Y., Ohkawa, R., Mishima, Y., Yatomi, Y., Analytical evaluation of plasma serotonin and sphingosine 1-phosphate and their clinical assessment in early atherosclerosis. Coron. Artery Dis. 23:4 (2012), 234–238.
20. Samy, S., Manjula, S., Salous, A.K., Leung, S.W., Berdyshev, E.V., Alison, B., Campbell, C.L., Richard, C., Morris, A.J., Smyth, S.S., Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions. Clin. Sci., 121(Pt 12), 2011, 565.
21. Sanchez, T., Estradahernandez, T., Paik, J.H., Wu, M.T., Venkataraman, K., Brinkmann, V., Claffey, K., Hla, T., Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J. Biol. Chem., 278(47), 2003, 47281.
22. Peng, X., Hassoun, P.M., Sammani, S., Mcverry, B.J., Burne, M.J., Rabb, H., Pearse, D., Tuder, R.M., Garcia, J.G.N., Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med., 169(11), 2004, 1245.
23. Mcverry, B.J., Peng, X., Hassoun, P.M., Sammani, S., Simon, B.A., Garcia, J.G., Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am. J. Respir. Crit. Care Med. 170:9 (2004), 987–993.
24. Park, S.J., Im, D.S., Sphingosine 1-phosphate receptor modulators and drug discovery. Biomol. Ther. 25:1 (2017), 80–90.
25. Zhang, Z., Li, W., Heng, Z., Jing, Z., Li, P., Xin, Y., Niu, W., Bai, C., Liu, H., Combination therapy of human umbilical cord mesenchymal stem cells and FTY720 attenuates acute lung injury induced by lipopolysaccharide in a murine model. Oncotarget 8:44 (2017), 77407–77414.
26. Metzker, M.L., Sequencing technologies - the next generation. Nat. Rev. Genet., 11(1), 2010, 31.
27. Müller, H.C., Hocke, A.C., Hellwig, K., Gutbier, B., Peters, H., Schönrock, S.M., Tschernig, T., Schmiedl, A., Hippenstiel, S., N'Guessan, P.D., The sphingosine-1 phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice. Pulm. Pharmacol. Ther., 24(4), 2011, 377.
28. Mrozek, J.D., Smith, K.M., Bing, D.R., Meyers, P.A., Simonton, S.C., Connett, J.E., Mammel, M.C., Exogenous surfactant and partial liquid ventilation: physiologic and pathologic effects. Am. J. Respir. Crit. Care Med. 156:1 (1997), 1058–1065.
29. Cai, S., Liu, A., Chen, S., He, H., Chen, Q., Xu, J., Pan, C., Yang, Y., Guo, F., Huang, Y., Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Stem Cell Res Ther, 6(1), 2015, 65.
30. Proia, R.L., Hla, T., Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J. Clin. Investig., 125(4), 2015, 1379.
31. Pyne, N.J., Ohotski, J., Bittman, R., Pyne, S., The role of sphingosine 1-phosphate in inflammation and cancer. Adv. Biol. Regul., 54, 2014, 121.
32. Guan, H., Song, L., Cai, J., Huang, Y., Wu, J., Yuan, J., Li, J., Li, M., Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS One, 6(5), 2011, e19946.
33. Fitzgerald, M., Mcauley, D.F., Matthay, M., Is there a need for emerging drugs for the acute respiratory distress syndrome?. Expert Opin. Emerg. Drugs 19:3 (2014), 323–328.
34. Lau, K.S., Juchheim, A.M., Cavaliere, K.R., Philips, S.R., Lauffenburger, D.A., Haigis, K.M., In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-α–induced apoptosis and proliferation by MAPKs. Sci. Signal., 4(165), 2011, ra16.
35. Bhatia, M., Moochhala, S., Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 202:2 (2004), 145–156.
36. Listed, N., Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 166:6 (2001), 3873–3881.
37. Okamoto, T., Gohil, K., Finkelstein, E.I., Bove, P., Akaike, T., Vliet, A.V.D., Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am. J. Phys. Lung Cell. Mol. Phys. 286:1 (2004), 198–209.
38. Hudson, W.H., Youn, C., Ortlund, E.A., The structural basis of direct glucocorticoid-mediated transrepression. Nat. Struct. Mol. Biol. 20:1 (2013), 53–58.
39. Lacey, J.M., Wilmore, D.W., Is glutamine a conditionally essential amino acid?. Nutr. Rev., 48(8), 1990, 297.
40. Perng, W.C., Huang, K.L., Li, M.H., Hsu, C.W., Tsai, S.H., Chu, S.J., Chang, D.M., Glutamine attenuates hyperoxia-induced acute lung injury in mice. Clin. Exp. Pharmacol. Physiol., 37(1), 2010, 56.
41. Last, J.A., Jr, K.T., Nerlich, A.G., Reiser, K.M., Collagen cross-linking in adult patients with acute and chronic fibrotic lung disease. Molecular markers for fibrotic collagen. Am. Rev. Respir. Dis., 141(2), 1990, 307.